The short version
- Metagenomic testing analyzed respiratory samples from over 100 critically ill children, identifying pathogens that standard diagnostic methods often miss.
- The results influenced clinical decisions in a quarter of cases, leading to changes in antibiotic prescriptions and helping combat antimicrobial resistance.
- Researchers suggest the technology could serve as an early detection tool for novel pathogens, with plans to expand its use across UK intensive care units.
A diagnostic approach that sequences all genetic material within a sample is reshaping how clinicians treat critically ill children in intensive care. Published research from Great Ormond Street Hospital in London demonstrates that this metagenomic testing can identify bacteria, viruses, and fungi that conventional methods frequently overlook. By providing a comprehensive view of the pathogens present, the technology allows medical teams to tailor treatments more precisely, potentially saving lives and reducing unnecessary antibiotic use.
The study, published in The Lancet Microbe, examined respiratory samples from 122 young patients admitted to the pediatric intensive care unit between 2024 and 2025. Unlike traditional diagnostics, which often require clinicians to predict the specific type of infection before testing, metagenomics scans for thousands of potential pathogens simultaneously. This broad-spectrum analysis proved capable of detecting approximately 90% of bacteria and viruses in the samples, along with all fungal organisms present.
The clinical impact was significant in a substantial portion of cases. In about one-quarter of the instances, the test results directly influenced prescribing decisions. Doctors used the data to start new antibiotics, stop ineffective ones, or switch medications entirely. This precision is critical in the fight against antimicrobial resistance, as it helps ensure that patients receive only the treatments necessary for their specific conditions, thereby reducing the pressure on bacteria to develop drug resistance.
The human stakes of this technology were illustrated by the case of Willow Crowther, a ten-year-old from Kent who suffered severe pneumonia leading to seizures and multiple cardiac arrests. Upon admission to Great Ormond Street Hospital, her family was told she had only a 50% chance of survival. Standard tests failed to identify the cause of her deterioration, but metagenomic sequencing revealed a drug-resistant bacterial infection. This finding prompted a change in her antibiotic regimen, which ultimately contributed to her recovery after several months of hospitalization.
Traditional diagnostic methods rely heavily on culturing bacteria in Petri dishes, a technique that has remained largely unchanged since the Victorian era. While polymerase chain reaction (PCR) tests offer faster results for specific viruses and bacteria, they require clinicians to specify what they are looking for in advance. Metagenomics removes this constraint by analyzing all genetic material present in a sample, allowing for the detection of unexpected or rare pathogens that might otherwise go unnoticed until it is too late.
Beyond individual patient care, the technology offers broader public health benefits. The study identified 50 organisms that routine diagnostics had missed, highlighting the method's potential as an early warning system for new infections. Researchers note that this capability could be vital in detecting novel pathogens that might pose pandemic threats. By identifying unknown agents quickly, health systems could implement containment measures sooner than with current surveillance tools.
The initiative at Great Ormond Street builds on earlier trials conducted at Guy's and St Thomas' NHS Trust, which first applied metagenomics to adult patients with respiratory infections. The success of these pediatric studies has prompted a gradual rollout of the testing service to approximately 30 intensive care units across the United Kingdom. These facilities treat both adults and children, expanding the reach of this diagnostic tool beyond specialized pediatric centers.
While the results are promising, the technology is still being integrated into standard clinical practice. The shift from hypothesis-driven testing to broad genetic sequencing represents a significant change in diagnostic workflow. As more data becomes available, clinicians will continue to refine how they interpret these complex results. For now, the evidence suggests that metagenomics offers a powerful new lens for viewing infectious diseases, particularly in cases where traditional methods fall short.
The implications extend beyond immediate treatment decisions. By improving the accuracy of diagnosis, this approach may reduce the length of hospital stays and improve long-term outcomes for critically ill children. It also provides a framework for monitoring antimicrobial resistance patterns in real time. As the technology becomes more widely available, it could transform how hospitals manage infectious diseases, moving from reactive treatment to proactive, data-driven care.
Future developments will likely focus on speeding up the analysis process and reducing costs to make the technology accessible to more facilities. The current rollout in the UK serves as a model for other health systems considering similar implementations. As researchers continue to study the long-term effects of metagenomic-guided treatment, the initial findings offer a compelling case for integrating advanced genetic sequencing into routine intensive care protocols.
Sources behind this briefing
Go to the original reporting
- BBC News↗Same-day test helps doctors detect hidden infections in critically ill children
